Synergistic induction of apoptosis by simultaneous disruption of the Bcl-2 and MEK/MAPK pathways in acute myelogenous leukemia

Blood

Volumn 99, Issue 9, 2002, Pages 3461-3464

  Milella, Michele ^a,b   Estrov, Zeev ^a,b   Kornblau, Steven M ^a,b   Carter, Bing Z ^a,b   Konopleva, Marina ^a,b   Tari, Ana ^a,b   Schober, Wendy D ^a,b   Harris, David ^a,b   Leysath, Clinton E ^a,b   Lopez Berestein, Gabriel ^a,b   Huang, Ziwei ^a,b   Andreeff, Michael ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 CHLORO 4 IODOANILINO) N CYCLOPROPYLMETHOXY 3,4 DIFLUOROBENZAMIDE; 2 AMINO 6 BROMO 4 (1 CYANO 2 ETHOXY 2 OXOETHYL) 4H CHROMENE 3 CARBOXYLIC ACID ETHYL ESTER; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BCL 2; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; ARTICLE; CONCENTRATION RESPONSE; DRUG POTENTIATION; ENZYME INHIBITION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0036566242     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.9.3461     Document Type: Article

References (27)

1. Molecular genetics of acute myeloid leukaemia
2. High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy
3. Bax and PKCα modulate the prognostic impact of Bcl-2 expression in acute myelogenous leukemia
4. Expression of Bcl-2-related genes in normal and AML progenitors: Changes induced by chemotherapy and retinoic acid
5. Liposomal Bcl-2 antisense oligonucleotides enhance proliferation, sensitize AML to cytosine-arabinoside, and induce apoptosis independent of other anti-apoptotic proteins
6. Signal transduction through MAP kinase cascades
7. Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia
8. The MEK inhibitor, PD98059, reduces survival but does not block acute myeloid leukemia blast maturation in vitro
9. Serine/threonine phosphorylation in cytokine signal transduction
10. The roles of signaling by the p42/p44 mitogen-activated protein (MAP) kinase pathway; a potential route to radio-and chemo-sensitization of tumor cells resulting in the induction of apoptosis and loss of clonogenicity
11. Combined effects of aberrant MEK1 activity and BCL2 over-expression on relieving the cytokine dependency of human and murine hematopoietic cells
12. Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells
13. Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo
14. Cytokine-regulated expression of survivin in myeloid leukemia
15. Effect of interleukin-1 beta converting enzyme inhibitor on acute myelogenous leukemia progenitor proliferation
16. Co-expression of several molecular mechanisms of multidrug resistance and their significance for paclitaxel cytotoxicity in human AML HL-60 cells
17. Specificity and mechanism of action of some commonly used protein kinase inhibitors
18. Detection of changes in mitochondrial function during apoptosis by simultaneous staining with multiple fluorescent dyes and correlated multiparameter flow cytometry
19. Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors
20. Life-or-death decisions by the Bcl-2 protein family
21. Induction of mitochondrial permeability transition and cytochrome C release in the absence of caspase activation is insufficient for effective apoptosis in human leukemia cells
22. B-Raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK/Erk pathway
23. Posttranslational modification of Bcl-2 facilitates its proteasome-dependent degradation: Molecular characterization of the involved signaling pathway
24. Regulation of Bcl2 phosphorylation and potential significance for leukemic cell chemoresistance
25. Myeloid cell leukemia I is phosphorylated through two distinct pathways, one associated with extracellular signal-regulated kinase activation and the other with G2/M accumulation or protein phosphatase 1/2A inhibition
26. Genetic analysis of chemoresistance in primary murine lymphomas
27. Oncoprotein networks